Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: A Southwest Oncology Group study

Robert Chapman; John Crowley; Joel G. Lucas; Ben Lin Hom; Robert B. Livingston; Clarence B. Vaughn; Harry E. Hynes

doi:10.1007/BF00873920

Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: A Southwest Oncology Group study

Robert Chapman, John Crowley, Joel G. Lucas, Ben Lin Hom, Robert B. Livingston, Clarence B. Vaughn, Harry E. Hynes

Research output: Contribution to journal › Article › peer-review

Abstract

This trial employing MGBG, vinblastine, and cisplatin in patients with advanced NSCLC produced a 10% response rate with no durable responses. This is disappointing compared to previously cited studies, although the median overall survival of 7.0 months is comparable. The relatively mild toxicity noted in this trial suggests that more aggressive use of the same combination may be feasible.

Original language	English (US)
Pages (from-to)	91-92
Number of pages	2
Journal	Investigational New Drugs
Volume	11
Issue number	1
DOIs	https://doi.org/10.1007/BF00873920
State	Published - Feb 1993
Externally published	Yes

Keywords

cisplatin
mitogauzone
vinblastine

ASJC Scopus subject areas

Oncology
Pharmacology
Pharmacology (medical)

Access to Document

10.1007/BF00873920

Cite this

@article{546af25ad5a1481689f9ec9b50db727f,

title = "Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: A Southwest Oncology Group study",

abstract = "This trial employing MGBG, vinblastine, and cisplatin in patients with advanced NSCLC produced a 10% response rate with no durable responses. This is disappointing compared to previously cited studies, although the median overall survival of 7.0 months is comparable. The relatively mild toxicity noted in this trial suggests that more aggressive use of the same combination may be feasible.",

keywords = "cisplatin, mitogauzone, vinblastine",

author = "Robert Chapman and John Crowley and Lucas, {Joel G.} and Hom, {Ben Lin} and Livingston, {Robert B.} and Vaughn, {Clarence B.} and Hynes, {Harry E.}",

year = "1993",

month = feb,

doi = "10.1007/BF00873920",

language = "English (US)",

volume = "11",

pages = "91--92",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

number = "1",

}

TY - JOUR

T1 - Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer

T2 - A Southwest Oncology Group study

AU - Chapman, Robert

AU - Crowley, John

AU - Lucas, Joel G.

AU - Hom, Ben Lin

AU - Livingston, Robert B.

AU - Vaughn, Clarence B.

AU - Hynes, Harry E.

PY - 1993/2

Y1 - 1993/2

N2 - This trial employing MGBG, vinblastine, and cisplatin in patients with advanced NSCLC produced a 10% response rate with no durable responses. This is disappointing compared to previously cited studies, although the median overall survival of 7.0 months is comparable. The relatively mild toxicity noted in this trial suggests that more aggressive use of the same combination may be feasible.

AB - This trial employing MGBG, vinblastine, and cisplatin in patients with advanced NSCLC produced a 10% response rate with no durable responses. This is disappointing compared to previously cited studies, although the median overall survival of 7.0 months is comparable. The relatively mild toxicity noted in this trial suggests that more aggressive use of the same combination may be feasible.

KW - cisplatin

KW - mitogauzone

KW - vinblastine

UR - http://www.scopus.com/inward/record.url?scp=0027191381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027191381&partnerID=8YFLogxK

U2 - 10.1007/BF00873920

DO - 10.1007/BF00873920

M3 - Article

C2 - 8394299

AN - SCOPUS:0027191381

SN - 0167-6997

VL - 11

SP - 91

EP - 92

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 1

ER -

Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: A Southwest Oncology Group study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this